Barhemsys

Active Ingredient(s): Amisulpride
FDA Approved: * February 26, 2020
Pharm Company: * ACACIA PHARMA LTD
Category: Nausea & Vomiting

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Barhemsys Overview

Amisulpride is an antiemetic and antipsychotic medication used at lower doses intravenously to prevent and treat postoperative nausea and vomiting; and at higher doses orally and intramuscularly[medical citation needed] to treat schizophrenia and acute psychotic episodes. It is sold under the brand names Barhemsys[7] (as an antiemetic) and Solian, Socian, Deniban and others (as an antipsychotic).[4] It is also used to treat dysthymia.[8&...

Read more Barhemsys Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amisulpride

Recent Barhemsys Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Amisulpride
  • Solution: 5mg/2ml (2.5mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Amisulpride or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 5 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA